MatthewA.BeckerMD

PubMed

• Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study.
  Schumacher, H. R.,Becker, M. A.,Lloyd, E.,MacDonald, P. A.,Lademacher, C.> ;Rheumatology (Oxford). 2009 Jan 15
• Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosi...
  Hanitsch LG, Burmester G, Witt C, Hunzelmann N, Genth E, Krieg T, Lehmacher W, Melchers I, Meurer M, Müller-Ladner U, Schulze-Lohoff E, Becker M, Sunderkoetter C, Riem...> ;Rheumatology (Oxford). 2009-01-01
• A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout.
  Taylor WJ, Schumacher HR, Baraf HSB, Chapman P, Stamp L, Doherty M, McQueen F, Dalbeth N, Schlesinger N, Furst DE, Vazquez-Mellado J, Mellado JV, Becker MA, Kavanaugh ...> ;Ann. Rheum. Dis.. 2008-06-01
• Magnetic resonance imaging in the quantitative assessment of gouty tophi.
  Schumacher HR, Becker MA, Edwards NL, Palmer WE, MacDonald PA, Palo W, Joseph-Ridge N> ;Int. J. Clin. Pract.. 2006-04-01
• 151 citations
  Migration, cultural bereavement and cultural identity
  Dinesh Bhugra, Matthew A Becker> ;World Psychiatry. 2005 Feb 1
• Join now to see all